FDA Approved: EPINEPHRINE — Supplemental Application (BPI Labs, LLC)

View source ↗

Summary

FDA approved a supplemental application for EPINEPHRINE from BPI Labs, LLC (NDA 205029). This action finalizes an update to the product's labeling and indicatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaphylaxis
• Cardiac Arrest

Drugs mentioned

• EPINEPHRINE (EPINEPHRINE)

Snippet

SUPPL AP for EPINEPHRINE (EPINEPHRINE)